8603 Share Price | Fameglow Holdings Ltd. Stock Analysis & Recommendation

Results Declared: Fameglow Holdings Ltd. has declared results on 15 May 2026! Click here to unlock the latest financial performance

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Fameglow Holdings Ltd. with Similar Stocks

Aidigong Maternal & Child Health Ltd.Kindstar Globalgene Technology, Inc.EuroEyes International Eye Clinic Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Management Efficiency with a high ROCE of 33.03%

The company is Net-Debt Free

Healthy long term growth as Net Sales has grown by an annual rate of 50.28%

Flat results in Sep 25

With ROE of 39.50%, it has a Expensive valuation with a 43.36 Price to Book Value

Market Beating performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

HKD 6,691 Million ()

P/E

110.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.39

Return on Equity

39.50%

Price to Book

52.71

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

27.46%

6 Months

152.16%

1 Year

580.83%

2 Years

2375.76%

3 Years

921.25%

4 Years

2453.12%

5 Years

4568.57%

Fameglow Holdings Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

50.28%

EBIT Growth (5y)

26.55%

EBIT to Interest (avg)

3.78

Debt to EBITDA (avg)

0.28

Net Debt to Equity (avg)

0.08

Sales to Capital Employed (avg)

3.36

Tax Ratio

16.86%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

33.03%

ROE (avg)

36.57%

Valuation key factors

Factor

Value

P/E Ratio

110

Industry P/E

Price to Book Value

43.36

EV to EBIT

92.20

EV to EBITDA

40.80

EV to Capital Employed

31.55

EV to Sales

10.09

PEG Ratio

Dividend Yield

ROCE (Latest)

34.23%

ROE (Latest)

39.50%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Bullish

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Fameglow Holdings Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 45.39% vs 31.55% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 12.01% vs 148.78% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "435.30",
          "val2": "299.40",
          "chgp": "45.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "113.70",
          "val2": "90.60",
          "chgp": "25.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.00",
          "val2": "3.20",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.70",
          "val2": "40.80",
          "chgp": "12.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "123.80%",
          "val2": "148.40%",
          "chgp": "-2.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]